 This study suggests that increased levels of indolimine to 3-dioxygenase, IDEO, are associated with rosacea. Furthermore, the study found that female patients had higher levels of IDEO than male patients, suggesting that gender may play a role in the development of the condition. Additionally, the study showed that IDEO levels were higher in patients in remission period and with papulopastula type rosacea compared to healthy controls. This suggests that IDEO could potentially serve as a biomarker for rosacea, as it can differentiate between different stages of the disease. This article was authored by Marv Sena Odubsi, Sarkan Yazisi, Govind Ojkaya and others.